Indian Journal of Animal Research

  • Chief EditorK.M.L. Pathak

  • Print ISSN 0367-6722

  • Online ISSN 0976-0555

  • NAAS Rating 6.43

  • SJR 0.263

  • Impact Factor 0.5 (2023)

Frequency :
Monthly (January, February, March, April, May, June, July, August, September, October, November and December)
Indexing Services :
Science Citation Index Expanded, BIOSIS Preview, ISI Citation Index, Biological Abstracts, Scopus, AGRICOLA, Google Scholar, CrossRef, CAB Abstracting Journals, Chemical Abstracts, Indian Science Abstracts, EBSCO Indexing Services, Index Copernicus
Indian Journal of Animal Research, volume 52 issue 2 (february 2018) : 291-295

Effect of dry cow therapy on incidence of clinical mastitis, milk yield and composition in crossbred cows

Shiwani Tiwari, T.K. Mohanty, T.K. Patbandha, A. Kumaresan, M. Bhakat, Shital Gautam, Anjali Kumari, Narender Kumar, R.K. Baithalu
1<p>Livestock Production Management Section,&nbsp;ICAR- National Dairy Research Institute, Karnal-132 001, Haryana, India.</p>
Cite article:- Tiwari Shiwani, Mohanty T.K., Patbandha T.K., Kumaresan A., Bhakat M., Gautam Shital, Kumari Anjali, Kumar Narender, Baithalu R.K. (2016). Effect of dry cow therapy on incidence of clinical mastitis,milk yield and composition in crossbred cows . Indian Journal of Animal Research. 52(2): 291-295. doi: 10.18805/ijar.11170.

Mastitis is considered as one of the important production disease in dairy cows which incurs huge economic losses to dairy industry, despite considerable efforts has been dedicated to solve it for the last two decades. In the present study, the impact of dry cow therapy (DCT) on incidence of clinical mastitis, milk yield and composition in crossbred cows was studied. About 20 healthy crossbred cows were selected at dry-off and randomly allotted either to control or treatment group. Daily milk yield of cows was recorded up to 45 days post-partum and fortnightly separate quarter wise milk samples were collected for estimation of milk composition. While no quarter in the treatment group showed clinical mastitis, 33.33% of quarters in control group showed clinical mastitis within 45 days post-partum. Milk production increased by 9.71, 8.40 and 18.18% during first, second and third fortnight with overall value 11.84% during the entire 45 days post-calving period in DCT treated cows compared to control group. Also, the overall fat-corrected milk, solid-corrected milk and energy-corrected milk production following 45 days post-partum increased significantly (P<0.05) by 22.71, 23.70 and 22.80%, respectively in treated group than control group. However, overall mean milk components such as fat, protein, lactose, SNF and TS remained similar between treatment and control groups. Taken together, the above results indicated that DCT increased milk yield by reducing incidence of clinical mastitis during early lactation. 

  1. Ardalan, M., Banadaky, M.D. and Rezayazdi, K. (2010). Milk yield persistency and its relationship with health problems in Holstein dairy cows supplemented with different levels of ruminally protected methionine and choline. Archiv Tierzucht. 53: 266-276.

  2. Arruda, A.G., Godden, S., Rapnicki, P., Gorden, P., Timms, L., Aly, S.S., Lehenbauer, T.W., and Champagne, J. (2013). Randomized non-inferiority clinical trial evaluating 3 commercial dry cow mastitis preparations: I. Quarter-level outcomes. J. Dairy Sci. 96: 4419-4435

  3. Bansal, B.K., J. Hamann, O. Lind, S.T. Singh and P.S. Dhaliwal (2007). Somatic cell count and biochemical components of milk related to udder health in buffaloes. Ital. J. Anim. Sci. 6: 1035-1038.

  4. Berry, S.L., Maas, J. Kirk, J.H., Reynolds, J.P., Gardner, A.I. and Ahmadi, A. (1997). Effect of antimicrobial treatment at the end of lactation on milk yield, somatic cell count, and incidence of clinical mastitis during the subsequent lactation in dairy herd with a low prevalence of contagious mastitis. J. Am. Vet Med Assoc. 211: 207-211.

  5. Bradley, A.J., Breen, J.E., Payne, B. Williams, P. and Green, M.J. (2010). The use of a cephalonium containing dry cow therapy and an internal teat sealant, both alone and in combination. J. Dairy Sci. 93: 1566-1577. 

  6. Browning, J.W., Mein, G.A., Brightling, P., Nicholls, T.J. and Barton, M. (1994). Strategies for mastitis control: Dry cow therapy and culling. Aust. Vet. J. 71: 179-181. 

  7. Godden, S., Rapnicki, P., Stewart, S., Fetrow, J., Johnson, A., Bey, R. and Farnsworth, R. (2003). Effectiveness of an internal teat seal in the prevention of new intramammary infections during the dry and early-lactation periods in dairy cows when used with a dry cow intramammary antibiotic. J. Dairy Sci. 86: 3899-3911.

  8. Green, M.J., Green, L.E., Medley, G.F., Schukken, Y.H. and Bradley, A.J. (2002). Influence of dry period bacterial intramammary infection on clinical mastitis in dairy cows. J. Dairy Sci. 85: 2589-2599.

  9. Gundelach, Y., Kalscheuer, E., Hamann, H. and Hoedemaker, M. (2011). Risk factors associated with bacteriological cure, new infection, and incidence of clinical mastitis after dry cow therapy with three different antibiotics. J. Vet. Sci. 12: 227-233.

  10. Halasa, T., Nielen, M., Whist, A.C. and Osteras, O. (2009). Meta-analysis of dry cow management for dairy cattle. Part 2. Cure of existing intramammary infections. J. Dairy Sci. 92: 3150-3157. 

  11. Hortet, P. and Seegers, H. (1998). Loss in milk yield and related composition changes resulting from clinical mastitis in dairy cows: a review. Prev. Vet. Med. 37: 1-20.

  12. Jingar, S.C., Mehla, R.K., Singh, M., Kumar, A., Kantwa S.C. and Singh, N. (2014). Comparative study on the incidence of mastitis during different parities in cows and buffaloes. Indian J. Anim. Res. 48: 194-197.

  13. Johnson, A.P., Godden, S.M., Royster, E., Zuidhof, S., Miller, B. and Sorg, J. (2016). Randomized non-inferiority study evaluating the efficacy of 2 commercial dry cow mastitis formulations. J. Dairy Sci. 99: 593-607.

  14. Macmillan, K.L., Duirs, G.F. and Duganzich, D.M. (1983). Associations between dry cow therapy, clinical mastitis, and somatic cell count score with milk and fat production in ten New Zealand dairy herds. J. Dairy Sci. 66: 59-65.

  15. McDougall, S. (2010). A randomised, non-inferiority trial of a new cephalonium dry-cow therapy. N. Z. Vet. J. 58:45-58.

  16. NAAS. (2013). Mastitis management in dairy animals. Policy Paper No. 61, National Academy of Agricultural Sciences, New Delhi. pp. 1-12.

  17. Nawaz, H., Yaqoob, M. and Abdullah, M. (2007). Effect of feeding supplemental tallow on the performance of lactating Nili-ravi buffaloes. Turk. J. Vet. Anim. Sci. 31: 389-398. 

  18. Newton, H.T., Green, M.J., Benchaoui, H., Cracknell, V., Rowan, T. and Bradley, A.J. (2008). Comparison of the efficacy of cloxacillin alone and cloxacillin combined with an internal teat sealant for dry-cow therapy. Vet. Rec. 162:678-684. 

  19. Oliver, S.P., Lewis, M.J., Gillespie, B.E., Dowlen, H.H. Jaenicke, E.C. and Roberts, R.K. (2003). Prepartum antibiotic treatment of heifers: Milk production, milk quality and economic benefit. J. Dairy Sci. 86: 1187-1193.

  20. Owens, W.E., Nickerson, S.C., Boddie, R.L., Tomita, G.M. and Ray, C.H. (2001). Prevalence of mastitis in dairy heifers and effectiveness of antibiotic therapy. J. Dairy Sci. 84:814.

  21. Pal, S. (2003). Investigation of health disorder in dairy cattle and buffaloes during prepartum and postpartum period. M.V.Sc. Thesis, National Dairy Research Institute, Karnal, India.

  22. Patbandha, T.K., Marandi, S., Ravikala, K., Pathak, R., Maharana B.R. and Murthy. K.S. (2015). Association of milk components with intra-mammary inflammation in Jaffrabadi buffaloes. Veterinary World, 8: 989-993.

  23. Pinedo, P.J., Fleming,C. and Risco,C.A. (2012). Events occurring during the previous lactation, the dry period,and peripartum as risk factors for early lactation mastitisin cows receiving 2 different intramammary dry cow therapies. J. Dairy Sci. 95: 7015-7026.

  24. Sanford, C. J., Keefe, G. P., Dohoo, I. R., Leslie, K. E., Dingwell, R. T. DesCoteaux, L. and Barkema, H. W. (2006). Efficacy of using an internal teat sealer to prevent new intramammary infections in nonlactating dairy cattle. J. Am. Vet. Med. Assoc., 228:1565-1573. 

  25. Scherpenzeel, C.G.M., Den Uijl, I.E.M., Van Schaik, G., Olde Riekerink, R.G.M., Keurentjes, J. M. and Lam, T.J. (2014). Evaluation of the use of dry cow antibiotics in low somatic cell count cows. J. Dairy Sci. 97: 3606–3614.

  26. Schukken, Y. H., Wilson, D. J., Welcome, F., Garrison-Tikofsky, L. and Gonzalez, R. N. (2003). Monitoring udder health and milk quality using somatic cell counts. Vet. Res. 34: 579-596.

  27. Sharma, P.C. (2010). Genetic evaluation of Karan Fries cows for functional traits. Ph.D. Thesis, National Dairy Research Institute, Karnal, India.

  28. Woolford, M.W., Williamson, J. H. and Day, A.M. (1998). The prophylactic effect of a teat sealer on bovine mastitis during the dry period and the following lactation. NZ Vet. J., 46: 12-19.

Editorial Board

View all (0)